| scholarly article | Q13442814 |
| P2093 | author name string | Pogue-Geile MF | |
| Harrow M | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 427-439 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Schizophrenia Bulletin | Q4049133 |
| P1476 | title | Negative symptoms in schizophrenia: their longitudinal course and prognostic importance | |
| P478 | volume | 11 |
| Q34245341 | A Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia |
| Q35185643 | A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness |
| Q54345721 | A prospective longitudinal 10-year study of schizophrenia's three major factors and depression. |
| Q37939248 | Adjunct mirtazapine for negative symptoms of schizophrenia |
| Q51200971 | Affective impairment in young acute schizophrenics: its structure, course and prognostic significance |
| Q38028891 | An update on the epidemiology of schizophrenia |
| Q33791053 | Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis |
| Q52005610 | Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study. |
| Q40913178 | Construct validity of negative symptoms: an empirical and conceptual review |
| Q91988310 | Course and symptom and functional correlates of passivity symptoms in schizophrenia: an 18-year multi-follow-up longitudinal study |
| Q35450483 | Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data |
| Q46645356 | Electrodermal predictors of functional outcome and negative symptoms in schizophrenia |
| Q41743497 | Emerging roles for novel antipsychotic medications in the treatment of schizophrenia |
| Q60513754 | Excitatory amino acids, NMDA and sigma receptors: A role in schizophrenia? |
| Q50716056 | Executive functioning and psychopathological profile in relatives of individuals with deficit v. non-deficit schizophrenia: a pilot study. |
| Q41126423 | Gender differences in schizophrenia in three cultures. Results of the WHO collaborative study on psychiatric disability |
| Q51085414 | Generality and specificity of emotion-recognition deficit in schizophrenic patients with positive and negative symptoms |
| Q48592475 | Insight, neurocognitive function and symptom clusters in chronic schizophrenia |
| Q35649715 | Instruments measuring blunted affect in schizophrenia: a systematic review |
| Q33573953 | Is disorganization a feature of schizophrenia or a modifying influence: evidence of covariation of perceptual and cognitive organization in a non-patient sample |
| Q41376152 | Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? |
| Q33993701 | Long-term outcome of patients with schizophrenia: a review |
| Q37010792 | Longitudinal progression of negative symptoms in schizophrenia: a new look at an old problem |
| Q37411272 | Motivational and Behavioral Activation as an Adjunct to Psychiatric Rehabilitation for Mild to Moderate Negative Symptoms in Individuals with Schizophrenia: A Proof-of-Concept Pilot Study |
| Q47767785 | Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia |
| Q44780281 | N1 and P300 abnormalities in patients with schizophrenia, epilepsy, and epilepsy with schizophrenialike features |
| Q44874230 | Negative Symptoms in Chronic Schizophrenia Relationship to Duration of Illness |
| Q89939352 | Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment |
| Q33707635 | Negative symptoms in schizophrenia: avolition and Occam's razor |
| Q47587674 | Negative symptoms of psychosis: A life course approach and implications for prevention and treatment |
| Q37039975 | Negative symptoms, defect state and Huber's basic symptoms: A comparison of the concepts |
| Q38341462 | Neuroleptic-resistant schizophrenics |
| Q35531500 | Neuropsychiatric rehabilitation for persistent mental illness |
| Q41089632 | Outcome in untreated schizophrenia: a search for symptoms and traits with prognostic meaning in patients admitted to a mental hospital in the preneuroleptic era |
| Q47312040 | Patterns of outcome in schizophrenia in Hong Kong |
| Q41346456 | Positive and negative syndromes in schizophrenia as a function of chronicity |
| Q33921161 | Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. |
| Q36648517 | Psychomotor slowing in schizophrenia |
| Q34098343 | Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness |
| Q69676316 | Relationship between symptomatology and social disability. Empirical evidence from a follow-up study of schizophrenic patients |
| Q50717020 | Reliability and validity of the life functioning assessment inventory (L-FAI) for patients with psychosis. |
| Q67514895 | Schizophrenia |
| Q41231694 | Schizophrenia. A cognitive model and its implications for psychological intervention |
| Q50795269 | Self-monitoring as a familial vulnerability marker for psychosis: an analysis of patients, unaffected siblings and healthy controls. |
| Q36992707 | Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery |
| Q48821424 | Slow‐wave sleep deficits and outcome in schizophrenia and schizoaffective disorder |
| Q35785068 | Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia |
| Q48144270 | Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study |
| Q73914992 | Sucrose and quinine intake by maternally-deprived and control rhesus monkeys |
| Q51109357 | Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia |
| Q68485608 | Temporal course of symptoms and social functioning in relapsing schizophrenics: A 6-year follow-up |
| Q46701681 | The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity |
| Q30364829 | The current conceptualization of negative symptoms in schizophrenia |
| Q53719209 | The deficit syndrome in first-admission patients with psychotic and non-psychotic disorders. |
| Q63866035 | The limbic-striatal interaction: A seesaw rather than a tandem |
| Q56896418 | The neuropsychology of schizophrenia: A perspective from neurobehavioral genetics |
| Q41178359 | The relationship of negative schizophrenia to parkinsonism |
| Q42156649 | The stability of symptoms and syndromes in chronic schizophrenic patients. |
| Q41723386 | Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study |
| Q46685755 | Where are patients who have co-occurring mental and physical diseases located? |
| Q57403541 | Why don't preschizophrenic children have delusions and hallucinations? |
| Q77478455 | [Symptoms and social functioning features in chronic schizophrenia are aggregate in a tripartite structure] |
Search more.